Increase In Injectable Treatment For Blood Clots In Advanced Cancer Patients

[News]

The use of an injectable, clot-preventing drug known as Low Molecular Weight Heparin to treat patients with advanced cancer complicated by blood clots increased steadily between 2000 and 2007, according to a new study published in The Oncologist, funded by the National Cancer Institute and led by Kaiser Permanente Colorado...

More... (http://www.medicalnewstoday.com/releases/241644.php)